Home » Topics » BioWorld Science

BioWorld Science
RSS

Muscarinic acetylcholine M3 receptor positive allosteric modulators patented by Nippon Shinyaku

Nov. 27, 2019

Janssen Pharmaceutica presents dual SGLT1 and SGLT2 inhibitors

Nov. 27, 2019

New monocarboxylate transporter 4 inhibitors identified at AstraZeneca

Nov. 27, 2019

Dizal Pharmaceutical describes new HER2 inhibitors

Nov. 27, 2019

Preliminary phase I/II data presented for olutasidenib in advanced IDH1-mutant gliomas

Nov. 27, 2019

NOTCH3 expression as a predictor of poor survival in patients with ESCC

Nov. 27, 2019

Targeting miR-26a shows therapeutic potential in model of abdominal aortic aneurysm

Nov. 27, 2019

Successful completion of Stage 2 of phase II study of prexigebersen plus decitabine in AML

Nov. 27, 2019

FDA approves Exservan oral film for the treatment of ALS

Nov. 27, 2019

DNDi receives financial support development of drugs for sleeping sickness and river blindness

Nov. 27, 2019

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...